摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-fluoro-2,4-dihydroxy-phenyl)-ethanone

中文名称
——
中文别名
——
英文名称
1-(3-fluoro-2,4-dihydroxy-phenyl)-ethanone
英文别名
1-(3-fluoro-2,4-dihydroxyphenyl)ethanone
1-(3-fluoro-2,4-dihydroxy-phenyl)-ethanone化学式
CAS
——
化学式
C8H7FO3
mdl
——
分子量
170.14
InChiKey
HFXKTKMEJTWQOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-(3-fluoro-2,4-dihydroxy-phenyl)-ethanone 、 在 caesium carbonate 作用下, 以 丙酮 为溶剂, 生成 6-[3-(4-acetyl-2-fluoro-3-hydroxy-phenoxymethyl)-phenoxy]-nicotinonitrile
    参考文献:
    名称:
    Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache
    摘要:
    Pyridylmethylsulfonamide series were the first reported example of positive allosteric modulators (PAM) of the mGlu(2) receptor. The hydroxyacetophenone scaffold is a second series of mGlu(2) PAMs we have identified. This series of molecules are potent mGlu(2) potentiators and possess significant CysLT1 (cysteinyl leukotriene receptor 1) antagonist activity, showing in vivo efficacy in a dural plasma protein extravasation (PPE) model of migraine. In this paper, we describe the dual SAR, pharmacokinetics and preclinical in vivo efficacy data for a tetrazole containing hydroxyacetophenone scaffold. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2016.11.049
  • 作为产物:
    参考文献:
    名称:
    WO2006/57860
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Potentiators Of Glutamate Receptors
    申请人:AICHER Thomas Daniel
    公开号:US20090318481A1
    公开(公告)日:2009-12-24
    This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine. This application also relates to processes for preparing a compound of formula I, and intermediate compounds useful therein.
    本申请涉及一种公式I的取代羟基苯酮化合物,或其药学上可接受的盐,及其在治疗偏头痛中的应用,以及制备公式I化合物的过程和其中有用的中间体化合物的应用。
  • Potentiators of Glutamate Receptors
    申请人:Aicher Daniel Thomas
    公开号:US20080004321A1
    公开(公告)日:2008-01-03
    The present invention provides a compound of formula (I): pharmaceutical compositions thereof, and methods of using the same, processes for preparing the same, and intermediates thereof.
    本发明提供了化合物(I)的配方:其制药组合物,使用该组合物的方法,制备该组合物的过程以及其中间体。
  • Potentiators of glutamate receptors
    申请人:Eli Lilly and Company
    公开号:US07858646B2
    公开(公告)日:2010-12-28
    The present invention provides compounds of formula (I); pharmaceutical compositions thereof, and methods of using the same, processes or preparing the same, and intermediates thereof.
    本发明提供了式(I)的化合物;其制药组合物,使用方法,制备方法或中间体。
  • POTENTIATORS OF GLUTAMATE RECEPTORS
    申请人:ELI LILLY AND COMPANY
    公开号:EP1817296A1
    公开(公告)日:2007-08-15
  • US7598423B2
    申请人:——
    公开号:US7598423B2
    公开(公告)日:2009-10-06
查看更多